ASKA Pharmaceutical Holdings Co Ltd
TSE:4886

Watchlist Manager
ASKA Pharmaceutical Holdings Co Ltd Logo
ASKA Pharmaceutical Holdings Co Ltd
TSE:4886
Watchlist
Price: 2 050 JPY 0.69% Market Closed
Market Cap: 58.1B JPY
Have any thoughts about
ASKA Pharmaceutical Holdings Co Ltd?
Write Note

ASKA Pharmaceutical Holdings Co Ltd
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

ASKA Pharmaceutical Holdings Co Ltd
Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
ASKA Pharmaceutical Holdings Co Ltd
TSE:4886
Long-Term Debt
ÂĄ4.5B
CAGR 3-Years
-31%
CAGR 5-Years
-19%
CAGR 10-Years
N/A
Takeda Pharmaceutical Co Ltd
TSE:4502
Long-Term Debt
ÂĄ4.4T
CAGR 3-Years
3%
CAGR 5-Years
-2%
CAGR 10-Years
18%
Daiichi Sankyo Co Ltd
TSE:4568
Long-Term Debt
ÂĄ101.1B
CAGR 3-Years
-11%
CAGR 5-Years
-11%
CAGR 10-Years
-9%
Otsuka Holdings Co Ltd
TSE:4578
Long-Term Debt
ÂĄ147.8B
CAGR 3-Years
-5%
CAGR 5-Years
-10%
CAGR 10-Years
22%
Chugai Pharmaceutical Co Ltd
TSE:4519
Long-Term Debt
ÂĄ0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Astellas Pharma Inc
TSE:4503
Long-Term Debt
ÂĄ620.2B
CAGR 3-Years
45%
CAGR 5-Years
39%
CAGR 10-Years
98%
No Stocks Found

ASKA Pharmaceutical Holdings Co Ltd
Glance View

Market Cap
58.1B JPY
Industry
Pharmaceuticals

ASKA Pharmaceutical Holdings Co., Ltd. engages in the management of its group companies which are involved in the manufacture and sale of pharmaceuticals, quasi-drugs, food, veterinary drugs, feeds, feed additives, and medical devices. The company is headquartered in Minato-Ku, Tokyo-To. The company went IPO on 2021-04-01. The firm mainly operates in two business segments. The Pharmaceutical segment is mainly engaged in the manufacture, purchase and sale of pharmaceutical products. The Others segment is involved in the manufacture of veterinary drugs, the provision of clinical testing services, the outsourcing of testing services, the purchase and sale of medical equipment, as well as the sale of health foods.

Intrinsic Value
3 410.94 JPY
Undervaluation 40%
Intrinsic Value
Price

See Also

What is ASKA Pharmaceutical Holdings Co Ltd's Long-Term Debt?
Long-Term Debt
4.5B JPY

Based on the financial report for Mar 31, 2024, ASKA Pharmaceutical Holdings Co Ltd's Long-Term Debt amounts to 4.5B JPY.

What is ASKA Pharmaceutical Holdings Co Ltd's Long-Term Debt growth rate?
Long-Term Debt CAGR 5Y
-19%

Over the last year, the Long-Term Debt growth was -51%. The average annual Long-Term Debt growth rates for ASKA Pharmaceutical Holdings Co Ltd have been -31% over the past three years , -19% over the past five years .

Back to Top